These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30548936)

  • 21. Resistance-Associated Mutations and Polymorphisms among Integrase Inhibitor-Naïve HIV-1 Patients in Kuwait.
    Chehadeh W; Albaksami O; John SE; Al-Nakib W
    Intervirology; 2017; 60(4):131-137. PubMed ID: 29212076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals.
    Jiamsakul A; Chaiwarith R; Durier N; Sirivichayakul S; Kiertiburanakul S; Van Den Eede P; Ditangco R; Kamarulzaman A; Li PC; Ratanasuwan W; Sirisanthana T;
    J Med Virol; 2016 Feb; 88(2):234-43. PubMed ID: 26147742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.
    Quashie PK; Oliviera M; Veres T; Osman N; Han YS; Hassounah S; Lie Y; Huang W; Mesplède T; Wainberg MA
    J Virol; 2015 Mar; 89(6):3163-75. PubMed ID: 25552724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering.
    Novitsky V; Zahralban-Steele M; McLane MF; Moyo S; van Widenfelt E; Gaseitsiwe S; Makhema J; Essex M
    J Clin Microbiol; 2015 Aug; 53(8):2581-92. PubMed ID: 26041893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid identification of human immunodeficiency virus type 1 CRF01_AE and BC recombinants by subtype-specific PCR.
    Luo H; Su QJ; Shao YM; Xing H; Chen J; Liu W; Zhang ZY; Zang N; Xiao X; Liang H
    J Virol Methods; 2011 Feb; 171(2):339-44. PubMed ID: 21126539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group study.
    Nouhin J; Donchai T; Hoang KT; Ken S; Kamkorn J; Tran T; Ayouba A; Peeters M; Chaix ML; Lien TX; Nerrienet E; Ngo-Giang-Huong N
    Infect Genet Evol; 2011 Jan; 11(1):38-43. PubMed ID: 21094281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of drug resistance-associated mutations in human immunodeficiency virus type 1 integrase derived from drug-naive individuals in Surabaya, Indonesia.
    Kotaki T; Khairunisa SQ; Sukartiningrum SD; Witaningrum AM; Rusli M; Diansyah MN; Arfijanto MV; Rahayu RP; Nasronudin ; Kameoka M
    AIDS Res Hum Retroviruses; 2014 May; 30(5):489-92. PubMed ID: 24328535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.
    Li H; Liang S; Guo W; Zhuang D; Li L; Liu Y; Bao Z; Liu S; Wang X; Li T; Liu W; Li J
    J Virol Methods; 2014 Sep; 205():17-23. PubMed ID: 24814966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation.
    Jaffré J; Armenia D; Bellocchi MC; Wirden M; Carioti L; Lambert S; Valantin MA; Nguyen T; Simon A; Katlama C; Andreoni M; Perno CF; Calvez V; Ceccherini-Silberstein F; Marcelin AG; Todesco E
    J Antimicrob Chemother; 2017 May; 72(5):1537-1539. PubMed ID: 28088769
    [No Abstract]   [Full Text] [Related]  

  • 31. In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong.
    Chen JH; Wong KH; Li PC; Chan KK; Lee MP; To SW; Yam WC
    Hong Kong Med J; 2012 Feb; 18(1):20-4. PubMed ID: 22302906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong.
    Yam WC; Chen JH; Wong KH; Chan K; Cheng VC; Lam HY; Lee SS; Zheng BJ; Yuen KY
    J Clin Virol; 2006 Apr; 35(4):454-7. PubMed ID: 16386461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of genetic polymorphism of the integrase gene in the HIV-1 subtype A populations circulating in the Russian Federation].
    Gafarova IE; Turbina GI; Garaev MM
    Vopr Virusol; 2010; 55(5):20-4. PubMed ID: 21260991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotyping of B and non-B subtypes of human immunodeficiency virus type 1.
    Tong CY; Mullen J; Kulasegaram R; De Ruiter A; O'Shea S; Chrystie IL
    J Clin Microbiol; 2005 Sep; 43(9):4623-7. PubMed ID: 16145117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid detection of human immunodeficiency virus type 1 group M by a reverse transcription-loop-mediated isothermal amplification assay.
    Hosaka N; Ndembi N; Ishizaki A; Kageyama S; Numazaki K; Ichimura H
    J Virol Methods; 2009 May; 157(2):195-9. PubMed ID: 19186193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
    Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
    J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appearance of Drug Resistance Mutations Among the Dominant HIV-1 Subtype, CRF01_AE in Maumere, Indonesia.
    Indriati DW; Kotaki T; Khairunisa SQ; Witaningrum AM; Matondang MQY; Ueda S; Nasronudin ; Purnama A; Kurniawan D; Kameoka M
    Curr HIV Res; 2018; 16(2):158-166. PubMed ID: 29732988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.
    De Francesco MA; Izzo I; Properzi M; Gargiulo F; Caccuri F; Quiros-Roldan E; Castelli F; Caruso A; Focà E
    AIDS Res Hum Retroviruses; 2018 Jul; 34(7):570-574. PubMed ID: 29631420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG.
    de Baar MP; Timmermans EC; Bakker M; de Rooij E; van Gemen B; Goudsmit J
    J Clin Microbiol; 2001 May; 39(5):1895-902. PubMed ID: 11326010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro analysis of the susceptibility of HIV-1 subtype A and CRF01_AE integrases to raltegravir.
    Bellecave P; Malato L; Calmels C; Reigadas S; Parissi V; Andreola ML; Fleury H
    Int J Antimicrob Agents; 2014 Aug; 44(2):168-72. PubMed ID: 24935032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.